» Articles » PMID: 27642008

Pathological Classification of Human IPSC-derived Neural Stem/progenitor Cells Towards Safety Assessment of Transplantation Therapy for CNS Diseases

Abstract

The risk of tumorigenicity is a hurdle for regenerative medicine using induced pluripotent stem cells (iPSCs). Although teratoma formation is readily distinguishable, the malignant transformation of iPSC derivatives has not been clearly defined due to insufficient analysis of histology and phenotype. In the present study, we evaluated the histology of neural stem/progenitor cells (NSPCs) generated from integration-free human peripheral blood mononuclear cell (PBMC)-derived iPSCs (iPSC-NSPCs) following transplantation into central nervous system (CNS) of immunodeficient mice. We found that transplanted iPSC-NSPCs produced differentiation patterns resembling those in embryonic CNS development, and that the microenvironment of the final site of migration affected their maturational stage. Genomic instability of iPSCs correlated with increased proliferation of transplants, although no carcinogenesis was evident. The histological classifications presented here may provide cues for addressing potential safety issues confronting regenerative medicine involving iPSCs.

Citing Articles

Stem cell therapies for spinal cord injury in humans: A review of recent clinical research.

Sugai K, Nakamura M, Okano H, Nagoshi N Brain Spine. 2025; 5:104207.

PMID: 40027291 PMC: 11870206. DOI: 10.1016/j.bas.2025.104207.


Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains.

Kanemura Y, Yamamoto A, Katsuma A, Fukusumi H, Shofuda T, Kanematsu D Cells. 2024; 13(8.

PMID: 38667286 PMC: 11048851. DOI: 10.3390/cells13080671.


Regenerative Medicine for Spinal Cord Injury Using Induced Pluripotent Stem Cells.

Nagoshi N, Sugai K, Okano H, Nakamura M Spine Surg Relat Res. 2024; 8(1):22-28.

PMID: 38343414 PMC: 10853617. DOI: 10.22603/ssrr.2023-0135.


Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells.

Nguyen T, Chooi W, Jeon H, Chen J, Tan J, Roxby D Stem Cells Transl Med. 2024; 13(4):387-398.

PMID: 38321361 PMC: 11016845. DOI: 10.1093/stcltm/szae002.


Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation.

Isoda M, Sanosaka T, Tomooka R, Mabuchi Y, Shinozaki M, Andoh-Noda T Commun Biol. 2023; 6(1):611.

PMID: 37286713 PMC: 10247757. DOI: 10.1038/s42003-023-04995-9.


References
1.
Okano H, Temple S . Cell types to order: temporal specification of CNS stem cells. Curr Opin Neurobiol. 2009; 19(2):112-9. DOI: 10.1016/j.conb.2009.04.003. View

2.
Ishii A, Kimura T, Sadahiro H, Kawano H, Takubo K, Suzuki M . Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma. PLoS One. 2016; 11(1):e0147366. PMC: 4723051. DOI: 10.1371/journal.pone.0147366. View

3.
Kanemura Y, Mori H, Kobayashi S, Islam O, Kodama E, Yamamoto A . Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J Neurosci Res. 2002; 69(6):869-79. DOI: 10.1002/jnr.10377. View

4.
Gore A, Li Z, Fung H, Young J, Agarwal S, Antosiewicz-Bourget J . Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011; 471(7336):63-7. PMC: 3074107. DOI: 10.1038/nature09805. View

5.
Svendsen C, Caldwell M, Shen J, ter Borg M, Rosser A, Tyers P . Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol. 1997; 148(1):135-46. DOI: 10.1006/exnr.1997.6634. View